Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 405-412, Vol. 69, No. 1
Service de
Dermatologie1 and Institut de
Microbiologie,3 Centre Hospitalier Universitaire
Vaudois, Lausanne, Switzerland, and Department of Bacteriology,
University Clinics, University of Göttingen,
Germany2
Received 21 August 2000/Returned for modification 2 October
2000/Accepted 18 October 2000
Medically important yeasts of the genus Candida secrete
aspartic proteinases (Saps), which are of particular interest as
virulence factors. Like Candida albicans, Candida
tropicalis secretes in vitro one dominant Sap (Sapt1p) in a
medium containing bovine serum albumin (BSA) as the sole source of
nitrogen. Using the gene SAPT1 as a probe and under
low-stringency hybridization conditions, three new closely related gene
sequences, SAPT2 to SAPT4, encoding secreted
proteinases were cloned from a C. tropicalis
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.405-412.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Secreted Aspartic Proteinase Family of
Candida tropicalis
EMBL3
genomic library. All bands identified by Southern blotting of
EcoRI-digested C. tropicalis genomic DNA with
SAPT1 could be assigned to a specific SAP gene.
Therefore, the SAPT gene family of C. tropicalis is likely to contain only four members. Interestingly,
the SAPT2 and SAPT3 gene products, Sapt2p and
Sapt3p, which have not yet been detected in C. tropicalis
cultures in vitro, were produced as active recombinant enzymes with the
methylotrophic yeast Pichia pastoris as an expression
system. As expected, reverse transcriptase PCR experiments revealed a
strong SAPT1 signal with RNA extracted from cells grown in
BSA medium. However, a weak signal was obtained with all other
SAPT genes under several conditions tested, showing that
these SAPT genes could be expressed at a basic level.
Together, these experiments suggest that the gene products Sapt2p,
Sapt3p, and Sapt4p could be produced under conditions yet to be
described in vitro or during infection.
*
Corresponding author. Mailing address: Service de
Dermatologie, Laboratoire de Mycologie, BT422, Centre Hospitalier
Universitaire Vaudois, 1011 Lausanne, Switzerland. Phone: 41 21 314 0376. Fax: 41 21 314 0378. E-mail:
Michel.Monod{at}chuv.hospvd.ch.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|